These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7276072)

  • 1. Complement receptors on lymphocytes.
    Dierich MP
    J Cancer Res Clin Oncol; 1981; 101(1):65-7. PubMed ID: 7276072
    [No Abstract]   [Full Text] [Related]  

  • 2. Assays for membrane complement receptors.
    O'Rear LD; Ross GD
    Curr Protoc Immunol; 2001 May; Chapter 13():13.4.1-13.4.18. PubMed ID: 18432717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of a simple, specific, and sensitive test for the detection of detergent-solubilized C3b receptor.
    Dierich MP; Ehlen T; Mussel HH
    Immunobiology; 1981; 160(2):241-7. PubMed ID: 7319543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fc and C3 receptor patterns on two EBV- negative Burkitt lymphoma lines during acute exposure to EBV (P3HR-1 substrain).
    Jønsson V; Klein G
    Eur J Cancer (1965); 1981 Feb; 17(2):161-5. PubMed ID: 6266834
    [No Abstract]   [Full Text] [Related]  

  • 5. Cell surface phenotype in lymphoproliferative disease.
    Aisenberg AC; Wilkes BM; Long JC; Harris NL
    Am J Med; 1980 Feb; 68(2):206-13. PubMed ID: 6965562
    [No Abstract]   [Full Text] [Related]  

  • 6. Binding of fluid-phase complement components C3 and C3b to human lymphocytes.
    Sim E; Sim RB
    Biochem J; 1981 Sep; 198(3):509-18. PubMed ID: 7326019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement components on human lymphocytes.
    Wilson AB; Prichard-Thomas S; Gurner BW; Lachmann PJ; Coombs RR
    Clin Immunol Immunopathol; 1982 Jan; 22(1):118-27. PubMed ID: 6214346
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibitory effect of C3b on rosette formation of peripheral blood mononuclear cells with mouse erythrocytes.
    Dobozy A; Füst G; Kenderessy AS; Hunyadi J; Fábry Z; Simon N
    Clin Exp Immunol; 1982 Jul; 49(1):230-2. PubMed ID: 7127900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of solid-phase radioimmunoassay specific for human IgG or human C3b to detect Fc gamma or C3b receptors on human lymphoblastoid cell surfaces.
    Frade R; Barel M; Charriaut C
    Methods Enzymol; 1983; 93():155-63. PubMed ID: 6223196
    [No Abstract]   [Full Text] [Related]  

  • 10. Complement-dependent cellular cytotoxicity: lymphoblastoid lines that activate complement component 3 (C3) and express C3 receptors have increased sensitivity to lymphocyte-mediated lysis in the presence of fresh human serum.
    Ramos OF; Sármay G; Klein E; Yefenof E; Gergely J
    Proc Natl Acad Sci U S A; 1985 Aug; 82(16):5470-4. PubMed ID: 3895232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rosette formation test with mouse erythrocytes in chronic lymphatic leukosis: correlation with other membrane receptors].
    Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
    Boll Ist Sieroter Milan; 1978 Nov; 57(5):643-9. PubMed ID: 755489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of cell lines derived from undifferentiated lymphomas according to their expression of complement and Epstein-Barr virus receptors: implications for the relationship between African and American Burkitt's lymphoma.
    Freeman CB; Magrath IT; Benjamin D; Makuch R; Douglass EC; Santaella ML
    Clin Immunol Immunopathol; 1982 Oct; 25(1):103-13. PubMed ID: 7151335
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin.
    Benjamin D; Magrath IT; Freeman CB
    J Natl Cancer Inst; 1983 Nov; 71(5):897-902. PubMed ID: 6316012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunological analysis of human lymphocytes bearing different surface receptors].
    Sidorenko SP; Iudin VM; Fedorovskaia MI; Umanskiĭ IuA
    Tsitologiia; 1979 Feb; 21(2):186-90. PubMed ID: 311965
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the Epstein Barr virus receptor found on Raji cells. II. A comparison of lymphocyte binding sites for Epstein Barr virus and C3d.
    Hutt-Fletcher LM; Fowler E; Lambris JD; Feighny RJ; Simmons JG; Ross GD
    J Immunol; 1983 Mar; 130(3):1309-12. PubMed ID: 6218205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of C3 receptors on lymphoid cells with different complement sources.
    Dierich MP; Pellegrino MA; Ferrone S; Reisfeld RA
    J Immunol; 1974 May; 112(5):1766-73. PubMed ID: 4522461
    [No Abstract]   [Full Text] [Related]  

  • 17. Expression of CR1 and CR2 complement receptors following Epstein-Barr virus infection of Burkitt's lymphoma cell lines.
    Cohen JH; Fischer E; Kazatchkine MD; Lenoir GM; Lefevre-Delvincourt C; Revillard JP
    Scand J Immunol; 1987 Jun; 25(6):587-98. PubMed ID: 3037684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptors for the complement C3d component and the Epstein-Barr virus are quantitatively coexpressed on a series of B-cell lines and their derived somatic cell hybrids.
    Jønsson V; Wells A; Klein G
    Cell Immunol; 1982 Sep; 72(2):263-76. PubMed ID: 6983911
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface receptors of human neoplastic lymphoreticular cells.
    Braylan RC; Jaffe ES; Mann RB; Frank MM; Berard CW
    Haematol Blood Transfus; 1977; 20():47-53. PubMed ID: 344164
    [No Abstract]   [Full Text] [Related]  

  • 20. Complement receptors on Raji cells. The presence of a new type of C3 receptor.
    Okuda T; Tachibana T
    Immunology; 1980 Sep; 41(1):159-66. PubMed ID: 7429548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.